The 33rd Breakfast Meeting
date : 10/27/2011
On Thursday the 27th of October 2011, the Health and Global Policy Institute hosted its 33rd Breakfast Meeting. On this occasion we welcomed Haruka Sakamoto, General Manager of the International Division of the Ministry of Health, Labour and Welfare Minister’s Secretariat, to speak about the global trends in strategy for non-communicable diseases (NCDs) such as cancer, diabetes, cardiovascular disease and respiratory disease, as well as the role expected to be played by Japan.
Globally NCDs account for 63% of all causes of death with rates continuing to increase in developing countries, meaning that in recent years there has been an urgent need for a global strategy. In response to this trend, a U.N. High Level Meeting on NCDs was held at the U.N. Headquarters in New York for two days from the 19th September 2011, and a resolution on the need for international cooperation in tackling NCDs whose outcomes can be improved through better lifestyles and earlier detection and treatment, such as type 2 diabetes, heart attack, respiratory diseases and cancer, was adopted. Currently NCDs represent an extremely important health agenda that has drawn the attention of the world.
Having also participated in the U.N. High Level Meeting, Ms. Sakamoto led discussion with the participants on what kinds of initiatives Japan could take in this area with the knowledge it has as a leading country in the acceleration of the aging of its population. In addition to this, the kinds of domestic strategies that could be perfected in order to tackle the NCD problem in Japan as well as contributing to the global situation were also discussed.
Globally NCDs account for 63% of all causes of death with rates continuing to increase in developing countries, meaning that in recent years there has been an urgent need for a global strategy. In response to this trend, a U.N. High Level Meeting on NCDs was held at the U.N. Headquarters in New York for two days from the 19th September 2011, and a resolution on the need for international cooperation in tackling NCDs whose outcomes can be improved through better lifestyles and earlier detection and treatment, such as type 2 diabetes, heart attack, respiratory diseases and cancer, was adopted. Currently NCDs represent an extremely important health agenda that has drawn the attention of the world.
Having also participated in the U.N. High Level Meeting, Ms. Sakamoto led discussion with the participants on what kinds of initiatives Japan could take in this area with the knowledge it has as a leading country in the acceleration of the aging of its population. In addition to this, the kinds of domestic strategies that could be perfected in order to tackle the NCD problem in Japan as well as contributing to the global situation were also discussed.
Registration deadline: 2011-10-24
Exhibition date:2011-10-27
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)





